These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20335008)

  • 1. Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers.
    Smith RC; Zhubi A; Maloku E; Sershen H; Lajtha A; Davis JM; Costa E; Guidotti A
    Schizophr Res; 2010 Jun; 119(1-3):269-70. PubMed ID: 20335008
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of varenicline for smoking cessation in bipolar disorder.
    Goldberg JF
    J Clin Psychiatry; 2014 Jul; 75(7):773-4. PubMed ID: 25093473
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
    Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR
    Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
    Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers.
    Sutherland MT; Carroll AJ; Salmeron BJ; Ross TJ; Hong LE; Stein EA
    Biol Psychiatry; 2013 Oct; 74(7):538-46. PubMed ID: 23506999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute coronary syndrome: an uncommon serious complication of smoking cessation with varenicline].
    Sanz Sanz CL; Meyer García-Sipido E; Fuentes Ponte M; Del Nogal Sáez F
    Med Clin (Barc); 2014 Feb; 142(4):179-80. PubMed ID: 23706682
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats.
    Goutier W; Kloeze MB; McCreary AC
    Addict Biol; 2015 Mar; 20(2):248-58. PubMed ID: 24251901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia.
    Roh S; Hoeppner SS; Schoenfeld D; Fullerton CA; Stoeckel LE; Evins AE
    Psychopharmacology (Berl); 2014 Feb; 231(4):765-75. PubMed ID: 24114425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline for smoking cessation in the bipolar patient.
    Tofler IR
    J Clin Psychiatry; 2015 May; 76(5):625. PubMed ID: 26035192
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination treatment with varenicline and nicotine replacement therapy.
    Ebbert JO; Burke MV; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 May; 11(5):572-6. PubMed ID: 19351781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW; Brooks PR; Vetelino MG; Wirtz MC; Arnold EP; Huang J; Sands SB; Davis TI; Lebel LA; Fox CB; Shrikhande A; Heym JH; Schaeffer E; Rollema H; Lu Y; Mansbach RS; Chambers LK; Rovetti CC; Schulz DW; Tingley FD; O'Neill BT
    J Med Chem; 2005 May; 48(10):3474-7. PubMed ID: 15887955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
    Smith RC; Lindenmayer JP; Davis JM; Cornwell J; Noth K; Gupta S; Sershen H; Lajtha A
    Schizophr Res; 2009 May; 110(1-3):149-55. PubMed ID: 19251401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain activity and emotional processing in smokers treated with varenicline.
    Loughead J; Ray R; Wileyto EP; Ruparel K; O'Donnell GP; Senecal N; Siegel S; Gur RC; Lerman C
    Addict Biol; 2013 Jul; 18(4):732-8. PubMed ID: 21507156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Chengappa KN; Perkins KA; Brar JS; Schlicht PJ; Turkin SR; Hetrick ML; Levine MD; George TP
    J Clin Psychiatry; 2014 Jul; 75(7):765-72. PubMed ID: 25006684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline and P50 auditory gating in medicated schizophrenic patients: a pilot study.
    Waldo MC; Woodward L; Adler LE
    Psychiatry Res; 2010 Jan; 175(1-2):179-80. PubMed ID: 19959243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline disrupts prepulse inhibition only in high-inhibitory rats.
    Goktalay T; Buyukuysal S; Uslu G; Coskun AS; Yorgancioglu A; Kayir H; Uzbay T; Goktalay G
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():54-60. PubMed ID: 24632394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline but not cotinine increased the value of a visual stimulus reinforcer in rats: No evidence for synergy of the two compounds.
    Houser SD; McNealy KR; Barrett ST; Bevins RA
    Pharmacol Biochem Behav; 2024 Feb; 235():173702. PubMed ID: 38154590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
    Steensland P; Simms JA; Holgate J; Richards JK; Bartlett SE
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12518-23. PubMed ID: 17626178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nicotine and neurologic diseases--even a noxious substance may possess beneficial properties].
    Kaakkola S; Tuominen R
    Duodecim; 2013; 129(16):1654-60. PubMed ID: 24069634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.